Reproxalap may be a viable new therapy option for patients with allergic conjunctivitis, according to a study published in Clinical Ophthalmology.
Source: Dermatology Advisor
Reproxalap may be a viable new therapy option for patients with allergic conjunctivitis, according to a study published in Clinical Ophthalmology.
Source: Dermatology Advisor